Literature DB >> 7018968

Correlation of urinary excretion of C-peptide with the integrated concentration and secretion rate of insulin.

M T Meistas, Z Zadik, S Margolis, A A Kowarski.   

Abstract

The secretion rate of insulin (SR-I) of 50 normal subjects was calculated from the 24-h integrated concentration of insulin (IC-I), the peripheral metabolic clearance of insulin (pMCR-I), and the mean fractional hepatic insulin extraction (fhMCR-I) that was derived from our data. fhMCR-I was determined as the difference in the molar secretory rate of C-peptide (SR-C) and the molar peripheral clearance of insulin (pMCR-I x IC-I) divided by SR-C. The IC-I in our 50 subjects was 1.19 +/- 0.38 ng/ml and the IC-C was 2.93 +/- 0.58 ng/ml. Based on these data, the fhMCR-I was 0.40 and the Sr-I was estimated to be 54.8 +/- 18.0 U/24 h. The 24-h urinary C-peptide excretion (U-C), 44.9 +/- 20.4 micrograms/24 h, had a statistically significant correlation with SR-I (r = 0.838, P less than 0.0001), while the IC-I correlated significantly with the 24-h urinary C-peptide/g of creatinine (r = 0.838, P less than 0.0001). The U-C may thus serve as a practical method for estimating the SR-I.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018968     DOI: 10.2337/diab.30.8.639

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  C-peptide measurement in the differentiation of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  H L Katzeff; P J Savage; B Barclay-White; M Nagulesparan; P H Bennett
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

2.  Separation of physiological factors influencing glucose-insulin kinetics in diabetic patients.

Authors:  B G Min; E J Woo; H K Lee; H K Min
Journal:  Ann Biomed Eng       Date:  1985       Impact factor: 3.934

3.  C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.

Authors:  K S Polonsky; W Pugh; J B Jaspan; D M Cohen; T Karrison; H S Tager; A H Rubenstein
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

4.  Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.

Authors:  H J Gjessing; L E Matzen; O K Faber; A Frøland
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

5.  Basal and 24-h C-peptide and insulin secretion rate in normal man.

Authors:  Y T Kruszynska; P D Home; I Hanning; K G Alberti
Journal:  Diabetologia       Date:  1987-01       Impact factor: 10.122

6.  Renal and splanchnic exchange of human biosynthetic C-peptide in type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Sjöberg; B L Johansson; J Ostman; J Wahren
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

7.  Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.

Authors:  K S Polonsky; J Licinio-Paixao; B D Given; W Pugh; P Rue; J Galloway; T Karrison; B Frank
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

8.  Quantitative study of insulin secretion and clearance in normal and obese subjects.

Authors:  K S Polonsky; B D Given; L Hirsch; E T Shapiro; H Tillil; C Beebe; J A Galloway; B H Frank; T Karrison; E Van Cauter
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

9.  The effect of age and body size on the urinary excretion of C-peptide from birth to 14 years of age.

Authors:  G Gács; P Jakabfi; L Zubovich
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

10.  Clinical application of the 24-H urinary C-peptide excretion rate and its relationship to metabolic control in diabetics.

Authors:  R Pasquali; P Biso; G Baraldi; L Mattioli; M Capelli; F Pasqui; N Melchionda
Journal:  Acta Diabetol Lat       Date:  1983 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.